LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 58

Search options

  1. Article ; Online: Management of liver diseases during the pandemic of coronavirus disease-19.

    Cho, Ju-Yeon / Kim, Soon Sun / Lee, Young-Sun / Song, Do Seon / Lee, Jeong-Hoon / Kim, Ji Hoon

    Clinical and molecular hepatology

    2020  Volume 26, Issue 3, Page(s) 243–250

    MeSH term(s) Antiviral Agents/therapeutic use ; Betacoronavirus/isolation & purification ; COVID-19 ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/therapy ; Coronavirus Infections/complications ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/pathology ; Cross Infection/prevention & control ; Drug Interactions ; Humans ; Immunosuppressive Agents/therapeutic use ; Liver Diseases/complications ; Liver Diseases/pathology ; Liver Diseases/prevention & control ; Liver Neoplasms/pathology ; Liver Neoplasms/therapy ; Liver Transplantation ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/pathology ; SARS-CoV-2
    Chemical Substances Antiviral Agents ; Immunosuppressive Agents
    Keywords covid19
    Language English
    Publishing date 2020-06-23
    Publishing country Korea (South)
    Document type Journal Article ; Practice Guideline
    ZDB-ID 2672560-5
    ISSN 2287-285X ; 2287-2728
    ISSN (online) 2287-285X
    ISSN 2287-2728
    DOI 10.3350/cmh.2020.0111
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline.

    Cho, Ju-Yeon / Lee, Young-Sun / Kim, Soon Sun / Song, Do Seon / Lee, Jeong-Hoon / Kim, Ji Hoon

    Clinical and molecular hepatology

    2021  Volume 27, Issue 4, Page(s) 515–523

    MeSH term(s) COVID-19 ; Disease Management ; Humans ; Liver Neoplasms/epidemiology ; Pandemics ; SARS-CoV-2
    Language English
    Publishing date 2021-09-17
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 2672560-5
    ISSN 2287-285X ; 2287-2728
    ISSN (online) 2287-285X
    ISSN 2287-2728
    DOI 10.3350/cmh.2021.0293
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Management of liver diseases during the pandemic of coronavirus disease-19

    Cho, Ju-Yeon / Kim, Soon Sun / Lee, Young-Sun / Song, Do Seon / Lee, Jeong-Hoon / Kim, Ji Hoon

    Clin Mol Hepatol

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #612052
    Database COVID19

    Kategorien

  4. Article ; Online: Management of liver diseases during the pandemic of coronavirus disease-19

    Ju-Yeon Cho / Soon Sun Kim / Young-Sun Lee / Do Seon Song / Jeong-Hoon Lee / Ji Hoon Kim

    Clinical and Molecular Hepatology, Vol 26, Iss 3, Pp 243-

    2020  Volume 250

    Keywords sars-cov-2 ; covid-19 ; hepatocelluar carcinoma ; liver cirrhosis ; hepatitis ; Diseases of the digestive system. Gastroenterology ; RC799-869 ; covid19
    Language English
    Publishing date 2020-07-01T00:00:00Z
    Publisher Korean Association for the Study of the Liver
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic.

    Inchingolo, Riccardo / Acquafredda, Fabrizio / Tedeschi, Michele / Laera, Letizia / Surico, Gianmarco / Surgo, Alessia / Fiorentino, Alba / Spiliopoulos, Stavros / de'Angelis, Nicola / Memeo, Riccardo

    World journal of gastroenterology

    2021  Volume 27, Issue 25, Page(s) 3780–3789

    Abstract: ... worldwide regarding the management of hepatocellular carcinoma during the COVID-19 pandemic were reviewed. ... The coronavirus disease 2019 (COVID-19) pandemic has impacted hospital organization ... types of liver cancer, has also required a different management during this period in order to optimize ...

    Abstract The coronavirus disease 2019 (COVID-19) pandemic has impacted hospital organization, with the necessity to quickly react to face the pandemic. The management of the oncological patient has been modified by necessity due to different allocation of nurses and doctors, requiring new strategies to guarantee the correct assistance to the patients. Hepatocellular carcinoma, considered as one of the most aggressive types of liver cancer, has also required a different management during this period in order to optimize the management of patients at risk for and with this cancer. The aim of this document is to review recommendations on hepatocellular carcinoma surveillance and management, including surgery, liver transplantation, interventional radiology, oncology, and radiotherapy. Publications and guidelines from the main scientific societies worldwide regarding the management of hepatocellular carcinoma during the COVID-19 pandemic were reviewed.
    MeSH term(s) COVID-19 ; Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/therapy ; Humans ; Liver Neoplasms/epidemiology ; Liver Neoplasms/therapy ; Pandemics ; SARS-CoV-2
    Language English
    Publishing date 2021-07-28
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2185929-2
    ISSN 2219-2840 ; 1007-9327
    ISSN (online) 2219-2840
    ISSN 1007-9327
    DOI 10.3748/wjg.v27.i25.3780
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Assessing the impact of COVID-19 on liver cancer management (CERO-19).

    Muñoz-Martínez, Sergio / Sapena, Victor / Forner, Alejandro / Nault, Jean-Charles / Sapisochin, Gonzalo / Rimassa, Lorenza / Sangro, Bruno / Bruix, Jordi / Sanduzzi-Zamparelli, Marco / Hołówko, Wacław / El Kassas, Mohamed / Mocan, Tudor / Bouattour, Mohamed / Merle, Philippe / Hoogwater, Frederik J H / Alqahtani, Saleh A / Reeves, Helen L / Pinato, David J / Giorgakis, Emmanouil /
    Meyer, Tim / Villadsen, Gerda Elisabeth / Wege, Henning / Salati, Massimiliano / Mínguez, Beatriz / Di Costanzo, Giovan Giuseppe / Roderburg, Christoph / Tacke, Frank / Varela, María / Galle, Peter R / Alvares-da-Silva, Mario Reis / Trojan, Jörg / Bridgewater, John / Cabibbo, Giuseppe / Toso, Christian / Lachenmayer, Anja / Casadei-Gardini, Andrea / Toyoda, Hidenori / Lüdde, Tom / Villani, Rosanna / Matilla Peña, Ana María / Guedes Leal, Cassia Regina / Ronzoni, Monica / Delgado, Manuel / Perelló, Christie / Pascual, Sonia / Lledó, José Luis / Argemi, Josepmaria / Basu, Bristi / da Fonseca, Leonardo / Acevedo, Juan / Siebenhüner, Alexander R / Braconi, Chiara / Meyers, Brandon M / Granito, Alessandro / Sala, Margarita / Rodríguez-Lope, Carlos / Blaise, Lorraine / Romero-Gómez, Manuel / Piñero, Federico / Gomez, Dhanny / Mello, Vivianne / Pinheiro Alves, Rogerio Camargo / França, Alex / Branco, Fernanda / Brandi, Giovanni / Pereira, Gustavo / Coll, Susanna / Guarino, Maria / Benítez, Carlos / Anders, Maria Margarita / Bandi, Juan C / Vergara, Mercedes / Calvo, Mariona / Peck-Radosavljevic, Markus / García-Juárez, Ignacio / Cardinale, Vincenzo / Lozano, Mar / Gambato, Martina / Okolicsanyi, Stefano / Morales-Arraez, Dalia / Elvevi, Alessandra / Muñoz, Alberto E / Lué, Alberto / Iavarone, Massimo / Reig, Maria

    JHEP reports : innovation in hepatology

    2021  Volume 3, Issue 3, Page(s) 100260

    Abstract: Background & aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented ... decision-making.: Lay summary: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented ... intrahepatic cholangiocarcinoma, cared for around the world during the first COVID-19 pandemic wave.: Results ...

    Abstract Background & aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening or procedures has been interrupted or delayed because of the COVID-19 pandemic.
    Methods: An international survey evaluated the impact of the COVID-19 pandemic on clinical practice and clinical trials from March 2020 to June 2020, as the first phase of a multicentre, international, and observational project. The focus was on patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma, cared for around the world during the first COVID-19 pandemic wave.
    Results: Ninety-one centres expressed interest to participate and 76 were included in the analysis, from Europe, South America, North America, Asia, and Africa (73.7%, 17.1%, 5.3%, 2.6%, and 1.3% per continent, respectively). Eighty-seven percent of the centres modified their clinical practice: 40.8% the diagnostic procedures, 80.9% the screening programme, 50% cancelled curative and/or palliative treatments for LC, and 41.7% modified the liver transplantation programme. Forty-five out of 69 (65.2%) centres in which clinical trials were running modified their treatments in that setting, but 58.1% were able to recruit new patients. The phone call service was modified in 51.4% of centres which had this service before the COVID-19 pandemic (n = 19/37).
    Conclusions: The first wave of the COVID-19 pandemic had a tremendous impact on the routine care of patients with liver cancer. Modifications in screening, diagnostic, and treatment algorithms may have significantly impaired the outcome of patients. Ongoing data collection and future analyses will report the benefits and disadvantages of the strategies implemented, aiding future decision-making.
    Lay summary: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems globally. Herein, we assessed the impact of the first wave pandemic on patients with liver cancer and found that routine care for these patients has been majorly disrupted, which could have a significant impact on outcomes.
    Language English
    Publishing date 2021-02-23
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2589-5559
    ISSN (online) 2589-5559
    DOI 10.1016/j.jhepr.2021.100260
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: [Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review].

    Maev, I V / Osadchuk, M A

    Terapevticheskii arkhiv

    2022  Volume 94, Issue 11, Page(s) 1326–1332

    Abstract: ... of CoronaVIrus Disease 2019 (COVID-19). This aspect is most clinically relevant in patients with pre-existing ... chronic liver disease (CKD), who are at extremely high risk of severe COVID-19 and death. Risk factors ... for severe CKD, especially in people with liver cirrhosis and non-alcoholic fatty liver disease, are ...

    Abstract The hepatic consequences of SARS-CoV-2 infection are now recognized as an important component of CoronaVIrus Disease 2019 (COVID-19). This aspect is most clinically relevant in patients with pre-existing chronic liver disease (CKD), who are at extremely high risk of severe COVID-19 and death. Risk factors for severe CKD, especially in people with liver cirrhosis and non-alcoholic fatty liver disease, are the direct and indirect cytotoxic effects of coronavirus against the background of systemic inflammation, blood clotting disorders and immune dysfunction. The severe negative impact of the pandemic in the presence of CKD and the difficulties of patient relationships contribute to the progressive increase in the global burden of liver disease on the health system.
    MeSH term(s) Humans ; COVID-19 ; Pandemics ; SARS-CoV-2 ; Non-alcoholic Fatty Liver Disease/diagnosis ; Non-alcoholic Fatty Liver Disease/epidemiology ; Non-alcoholic Fatty Liver Disease/therapy ; Renal Insufficiency, Chronic
    Language Russian
    Publishing date 2022-12-26
    Publishing country Russia (Federation)
    Document type Review ; English Abstract ; Journal Article
    ZDB-ID 40718-5
    ISSN 2309-5342 ; 0040-3660
    ISSN (online) 2309-5342
    ISSN 0040-3660
    DOI 10.26442/00403660.2022.11.201934
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Management of Liver Tumors during the COVID-19 Pandemic

    Irene Bargellini / Giuseppe Boni / Antonio Claudio Traino / Elena Bozzi / Giulia Lorenzoni / Francesca Bianchi / Rosa Cervelli / Tommaso Depalo / Laura Crocetti / Duccio Volterrani / Roberto Cioni

    Journal of Clinical Medicine, Vol 10, Iss 4315, p

    The Added Value of Selective Internal Radiation Therapy (SIRT)

    2021  Volume 4315

    Abstract: Background: In the context of the coronavirus disease 2019 (COVID-19) pandemic, liver-directed ... of this study is to present our experience with SIRT during the first wave of COVID-19 pandemic and provide ... 56.7% and 72.2%, respectively. Conclusion: The first wave of the COVID-19 pandemic was characterized ...

    Abstract Background: In the context of the coronavirus disease 2019 (COVID-19) pandemic, liver-directed therapies (LDTs) may offer minimally invasive integrative tools for tumor control. Among them, selective internal radiation therapy (SIRT) represents a safe, flexible and effective treatment. Purpose of this study is to present our experience with SIRT during the first wave of COVID-19 pandemic and provide an overview of the indications and challenges of SIRT in this scenario. Methods: We retrospectively analyzed the number of patients evaluated by Multidisciplinary Liver Tumor Board (MLTB) and who were undergoing LDTs between March and July 2020 and compared it with 2019. For patients treated with SIRT, clinical data, treatment details and the best radiological response were collected. Results: Compared to 2019, we observed a 27.5% reduction in the number of patients referred to MLTB and a 28.3% decrease in percutaneous ablations; transarterial chemoembolizations were stable, while SIRT increased by 64%. The majority of SIRT patients (75%) had primary tumors, mostly HCC. The best objective response and disease control rates were 56.7% and 72.2%, respectively. Conclusion: The first wave of the COVID-19 pandemic was characterized by an increased demand for SIRT, which represents a safe, flexible and effective treatment, whose manageability will further improve by simplifying the treatment workflow, developing user-friendly and reliable tools for personalized dosimetry and improving interdisciplinary communication.
    Keywords radioembolization ; yttrium ; holmium ; hepatocellular carcinoma ; cholangiocarcinoma ; liver cancer ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2021-09-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic.

    Gringeri, Enrico / Gambato, Martina / Furlanetto, Alessandro / Ballo, Mattia / Nieddu, Eleonora / Cillo, Umberto

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

    2020  Volume 52, Issue 9, Page(s) 944–945

    MeSH term(s) Betacoronavirus ; Bile Duct Neoplasms ; Bile Ducts, Intrahepatic ; COVID-19 ; Cholangiocarcinoma ; Coronavirus Infections ; Humans ; Klatskin Tumor ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-07-06
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 1459373-7
    ISSN 1878-3562 ; 1125-8055
    ISSN (online) 1878-3562
    ISSN 1125-8055
    DOI 10.1016/j.dld.2020.06.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Management of patients with autoimmune liver disease during COVID-19 pandemic.

    Lleo, Ana / Invernizzi, Pietro / Lohse, Ansgar W / Aghemo, Alessio / Carbone, Marco

    Journal of hepatology

    2020  Volume 73, Issue 2, Page(s) 453–455

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/prevention & control ; Coronavirus Infections/virology ; Hepatitis, Autoimmune/drug therapy ; Humans ; Immunocompromised Host ; Immunosuppressive Agents/therapeutic use ; Infection Control/methods ; Liver Cirrhosis/drug therapy ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Telemedicine/methods
    Chemical Substances Immunosuppressive Agents
    Keywords covid19
    Language English
    Publishing date 2020-04-10
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2020.04.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top